The University of Arizona Health Sciences is one of five sites that will be tracking the burden, distribution and impact of post COVID-19 conditions.
Continue reading
Author Archive: AZBio
Aqualung Therapeutics, an Immunotherapeutics Biotech Company, Receives First $1.5M Toward Series A Preferred Capital Raise; Will Present at 2023 Annual Biotech Showcase
-JSR Lifesciences invested $1.5M toward the preferred series A capital raise, October 2022.
-The dosing of the P1A Healthy Human Volunteer Study with ALT-100 mAb is nearing completion, with no reported SAEs to date. Study to conclude by Q2 2023.Continue reading
TapRoot Partners with Psychiatric Provider Group Peace of Mind Consultants to Use Ella®
TapRoot Interventions & Solutions, Inc (TapRoot) is partnering with psychiatric and behavioral health provider group Peace of Mind Consultants (POMC) in Arizona to provide Ella® to their patients and business partners. Ella is a digital careplan platform that provides interventions to prevent, decrease, and de-escalate dementia-related and mental illness-related behavioral symptoms known to occur in Long Term Care communities. POMC will use Ella to garner key insights from caregiver feedback in order to tailor patient-specific treatment plans and determine appropriate use of medications. The value of the partnership is a provider service model coupled with a caregiver platform to assess, evaluate, and provide outcome measures to improve overall resident care.Continue reading
NEW AZBio Member Benefit – Tax Credit Services from ADP
ADP provides an experienced and practical approach for guiding life science clients through the R&D tax credit process. Their group of specialized professionals provide the peace of mind that comes with having a highly detailed study outlining qualified research activities and expenses.Continue reading
Five Arizona Researchers Make the List of Top1,000 Female Scientists in the World
For the first time, Research.com has published a list of the top 1,000 female scientists in the world.
Congratulations to Barbara Ainsworth, Carol Barnes, Carolyn Compton, Nancy Eisenberg, and Alexandra Navrotsky for this well earned recognition.Continue reading
Arizona Tech Investors Announces New CEO
Bob DeLean to Direct Arizona’s Leading Angel Investing Group’s Next StageContinue reading
AZAdvances is working to support health innovation in Arizona
How You Can Help Advance Health InnovationContinue reading
U.S. Food and Drug Administration approves CSL’s HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B
- This historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy and generates elevated and sustained factor IX levels for years after a one-time infusion
- With the approval of HEMGENIX, CSL now offers an even more comprehensive portfolio of treatments for people living with hemophilia B, ushering in a new era of treatment options
Student Opportunity – 2023 KEYS Internships
The 2023 KEYS Research Internship applications opened November 21, 2022.Continue reading
Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer
PHOENIX, Arizona and OSLO, Norway — November 21, 2022 — Scientists at the Phoenix-based Translational Genomics Research Institute (TGen), part of City of Hope, and EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), a Norwegian clinical stage precision health company, today report that the ultrasound based Acoustic Cluster Therapy (ACT®) significantly enhanced the antitumor efficacy of standard care therapies in a preclinical model for pancreatic cancer.Continue reading